Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Foghorn Therapeutics Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 62 | 65 | +3 |
| Shares | 26.3M | 26.1M | −212.8K (−0.8%) |
| Value | $225.7M | $166.5M | −$59.2M (−26.2%) |
New holders (11)
Institutions that held Foghorn Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 109,991 | $701.7K | 0.32% |
| Wade G W & Inc | 107,770 | $688.0K | 0.03% |
| Cornercap Investment Counsel Inc | 26,163 | $166.9K | 0.03% |
| Man Group plc | 15,855 | $101.2K | 0.00% |
| UBS Group AG | 5,047 | $32.2K | 0.00% |
| Cubist Systematic Strategies, LLC | 1,400 | $8.93K | 0.00% |
| Nisa Investment Advisors, LLC | 525 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 425 | $2.71K | 0.00% |
| Daiwa Securities Group Inc. | 168 | $1.00K | 0.00% |
| Point72 Middle East FZE | 37 | $236 | 0.00% |
| Simplex Trading, LLC | 66 | $0 | 0.00% |
Sold out (8)
Institutions that held Foghorn Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Victory Capital Management Inc | 37,500 | $322.0K |
| HRT Financial LP | 11,785 | $101.0K |
| BNP Paribas Arbitrage, SA | 10,707 | $91.9K |
| Wedbush Securities Inc | 10,634 | $91.0K |
| Virtus ETF Advisers LLC | 8,258 | $71.0K |
| Point72 Hong Kong Ltd | 1,192 | $10.0K |
| US Bancorp | 3 | $0 |
| Lindbrook Capital, LLC | 23 | $0 |